openPR Logo
Press release

Global HIV-Associated Lipodystrophy Syndrome Market Outlook, Clinical Trials Review, H2, 2015: Acute Market Reports

03-07-2016 04:43 PM CET | Health & Medicine

Press release from: Acute Market Reports

Global HIV-Associated Lipodystrophy Syndrome Market Outlook,

Summary

GlobalData's clinical trial report, “HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of HIV-Associated Lipodystrophy Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on HIV-Associated Lipodystrophy Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Browse full report with TOC @ acutemarketreports.com/report/hiv-associated-lipodystrophy-syndrome-global-clinical-trials-review-h2-2015

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

View all reports of this category @ http://www.acutemarketreports.com/category/pharmaceutical-market

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Blog URL: http://www.mobilecomputingtoday.co.uk/

About Acute Market Reports
Acute Market Reports is the most sufficient collection of market intelligence services online. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.

Contact:
Chris Paul
Office No 01, 1st Floor,
Aditi Mall, Baner, Pune,
MH, 411045 India
Phone (India): +91 7755981103
Toll Free (US/Canada): +1-855-455-8662
Email: sales@acutemarketreports.com

For More Information, Visit http://www.acutemarketreports.com/

Acute Market Reports is the most sufficient collection of market intelligence services online. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.

Office No 01, 1st Floor,
Aditi Mall, Baner, Pune,
MH, 411045 India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HIV-Associated Lipodystrophy Syndrome Market Outlook, Clinical Trials Review, H2, 2015: Acute Market Reports here

News-ID: 325277 • Views: 418

More Releases from Acute Market Reports

Target Market for Mobile Travel Booking is gaining huge growth in upcoming years …
The mobile travel booking market was valued at US$ 858.0 Mn in 2018 and is set to grow with a CAGR of 12.2% during the forecast period. Market Insights The global market for mobile travel bookings is driven by the increasing adoption of mobile apps for a wide range of applications among consumers. Since the rise of smartphones, the market for mobile apps has changed considerably. The convenience and features offered by
Bronchitis Treatment Market Size, Share, Growth Is Expected To Reach US$ 4,606.3 …
According to the latest report published by Credence Research, Inc. “Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global Bronchitis Treatment market was valued at USD 3,345.8 Mn in 2017, and is expected to reach USD 4,606.3 Mn by 2026, expanding at a CAGR of 4.9% from
5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025
The latest market report published by Credence Research, Inc. “Global Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026. Market Insights According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all
Floating Solar Panels Market: Global Industry Share, Market Trends and Forecast …
According to a new market report published by Credence Research Global Floating Solar Panels Market- Growth, Future Prospects & Competitive Analysis, 2016 - 2023, the Global Floating Solar Panels Market is expected to reach US$ 842.0 Mn by 2023, expanding at a CAGR of 65.1% during the forecast period 2016 to 2023. Browse the full Global Floating Solar Panels Market by Product Type, Location and Geography - Growth, Future Prospects &

All 5 Releases


More Releases for Lipodystrophy

Lipodystrophy Therapeutics- Pipeline Analysis 2018 | Ionis Pharmaceuticals, Inc. …
Lipodystrophy is a rare medical condition which involves problems with fat production, usage, and storage. It is categorized into two types; congenital and acquired lipodystrophy. Download the sample report @ https://www.pharmaproff.com/request-sample/1077 Congenital lipodystrophies include congenital generalized lipodystrophy, familial partial lipodystrophy, and marfanoid progeroid lipodystrophy syndrome; while acquired lipodystrophy includes acquired partial lipodystrophy, acquired generalized lipodystrophy, centrifugal abdominal lipodystrophy, lipoatrophia annularis, localized lipodystrophy and HIV-associated lipodystrophy. Get the detailed analysis @ https://www.pharmaproff.com/report/lipodystrophy-therapeutics-pipeline-analysis The
HIV-Associated Lipodystrophy Treatment Market - Global Industry Insights, Trends
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
HIV Associated Lipodystrophy Syndrome Market highlights on health benefits 2025
Global HIV Associated Lipodystrophy Syndrome Market: Snapshot HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus (HIV)-infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Patients have lipohypertrophy, an abnormal central fat accumulation or lipoatrophy, localized loss of fat tissue, or a mixed clinical presentations representing both. The complex morphological signs associated with lipodystrophy syndrome inhibits our understanding of the
HIV Associated Lipodystrophy Syndrome Market - Geographical Segmentation & Forec …
Global HIV Associated Lipodystrophy Syndrome Market: Snapshot HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus (HIV)-infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Patients have lipohypertrophy, an abnormal central fat accumulation or lipoatrophy, localized loss of fat tissue, or a mixed clinical presentations representing both. The complex morphological signs associated with lipodystrophy syndrome inhibits our understanding of the
HIV Associated Lipodystrophy Syndrome Market - Geographical Segmentation & Forec …
Global HIV Associated Lipodystrophy Syndrome Market: Snapshot HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus (HIV)-infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Patients have lipohypertrophy, an abnormal central fat accumulation or lipoatrophy, localized loss of fat tissue, or a mixed clinical presentations representing both. The complex morphological signs associated with lipodystrophy syndrome inhibits our understanding of the
HIV-associated Lipodystrophy Market - In-Depth Analysis & Forecast 2025
Changes in body fat concentration, affecting people with HIV, is known as HIV-associated lipodystrophy. The exact causes of this condition is currently unknown, but research suggests that this disorder can occur either due to HIV infection or as a consequence of side effects associated with drugs used in HIV infection treatment, such as Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs), Protease Inhibitors (PIs), etc. The lipodystrophy condition is characterized by metabolic abnormalities,